TyraTech 2.0: Why the company ’s going all in on animal health

Following a deal worth as much as $17.5 million to sell its cornerstone human head lice treatment Vamousse to U.K.-based Alliance Pharma, Morrisville ’s TyraTech is shifting gears to focus solely on its animal health business.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news